Hepatectomy for metastases from non-colorectal and non-neuroendocrine tumor.
BACKGROUND
The role of hepatectomy for metastases from non-colorectal (NCR) and non-neuroendocrine (NNE) tumors has not been defined. We analyzed several factors of the primary tumor and liver metastases to clarify the prognostic determinants.


METHODS
From 1990 to 1995, 33 patients underwent hepatectomy for metastases from NCR and NNE tumors. The primary tumors were gastric cancer in 9, biliary cancer in 7, pancreatic cancer in 6, breast cancer in 4 and miscellaneous tumor in 7 patients.


RESULTS
The overall 5-year survival after hepatectomy was 12.1%. Morbidity and mortality rates were 21.2% and 9.1%, respectively. The liver metastases from breast cancer, unilateral liver metastases and curative resection of liver metastases were prognostic factors in univariate analysis.


CONCLUSIONS
Resection of liver metastases from NCR and NNE tumors may offer prolonged survival for selected patients.
Yamada
H
H
Department of Surgical Oncology, Hokkaido University Graduate School of Medicine, Sapporo Japan. h-yamada@med.hokudai.ac.jp
Katoh
H
H
Kondo
S
S
Okushiba
S
S
Morikawa
T
T
D000328:Adult; D000368:Aged; D001661:Biliary Tract Neoplasms / Q000473:pathology; D001943:Breast Neoplasms / Q000473:pathology; D018572:Disease-Free Survival; D005260:Female; D006498:Hepatectomy; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009369:Neoplasms / Q000473:pathology*; D010190:Pancreatic Neoplasms / Q000473:pathology; D013274:Stomach Neoplasms / Q000473:pathology; D015996:Survival Rate